Cordasco Financial Network’s INmune Bio INMB Stock Holding History

Cordasco Financial Network’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Hold	100	–	–	﹤0.01%	559
2022 Q1	$1K	Buy	+100	New	+$898	﹤0.01%	530

Other funds holding INMB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cordasco Financial Network's INMB Position: Q2 2022 in Review

Cordasco Financial Network held its INmune Bio (INMB) position steady in Q2 2022 at 100 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

Cordasco Financial Network first reported a position in INMB in Q1 2022 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold INMB as of Q2 2022.

Cordasco Financial Network held 100 shares of INmune Bio worth $1K as of Q2 2022.
Cordasco Financial Network left its INmune Bio share count unchanged in Q2 2022.
INmune Bio made up ﹤0.01% of Cordasco Financial Network's portfolio in Q2 2022, its #559 holding.
Cordasco Financial Network first reported a position in INmune Bio in Q1 2022 and has held it in 2 quarters since.
36 funds tracked by Wall St. Rank held INmune Bio as of Q2 2022.

Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.